Search Orphan Drug Designations and Approvals
-
Generic Name: | humanized immunoglobulin G4-variant monoclonal antibody directed against the p19 subunit of interleukin (IL)-23 |
---|---|
Date Designated: | 06/15/2017 |
Orphan Designation: | Treatment of ulcerative colitis in pediatric patients |
Orphan Designation Status: | Designated |
FDA Orphan Approval Status: | Not FDA Approved for Orphan Indication |
Sponsor: |
Eli Lilly & Company Lilly Corporate Center Indianapolis, Indiana 46285 United States The sponsor address listed is the last reported by the sponsor to OOPD. |
*Data for the Date Designation Withdrawn or Revoked field are shown for designations withdrawn or revoked after 08/12/2013.
-